HomeTrust Bancshares Reports Strong Earnings Growth Amidst Deteriorating Asset Quality; Authorizes New Share Buyback
HTB sits 36% above its 52-week low of $30.95.
Summary
HomeTrust Bancshares reported strong 2025 earnings and authorized a new share buyback, but faced a significant increase in nonperforming assets and reduced loan loss coverage.
Key Events · Earnings and Guidance · HTB
-
Strong Annual Earnings Growth
Net income increased by 17.4% to $64.4 million, with diluted EPS rising 16.3% to $3.72 for the fiscal year ended December 31, 2025, compared to the prior year.
-
Deteriorating Asset Quality Metrics
Nonperforming assets surged 54.2% to $44.4 million, and the allowance for credit losses (ACL) coverage for nonperforming loans significantly decreased from 163.68% to 94.75%.
-
New Share Repurchase Program Authorized
The Board authorized the repurchase of an additional 870,000 shares of common stock, representing approximately 5% of the company's outstanding shares.
-
Strategic Loan Portfolio Adjustments
The company strategically reduced its equipment finance and indirect auto finance loan portfolios, while commercial and industrial loans experienced growth.
Analysis · HTB · Finance
HomeTrust Bancshares reported robust net income and EPS growth for fiscal year 2025, driven by increased noninterest income and controlled expenses. The company also authorized a new share repurchase program, signaling a commitment to returning capital to shareholders. However, these positive developments are overshadowed by a significant increase in nonperforming assets and a notable decline in the allowance for credit losses relative to nonperforming loans, indicating a deterioration in asset quality that warrants close investor attention. The strategic reduction in certain loan portfolios aims to mitigate risk, but the overall trend in problem loans is a key concern for the bank's financial health.
At the time of this filing, HTB was trading at $42.20 on NYSE in the Finance sector, with a market capitalization of approximately $736.1M. The 52-week trading range was $30.95 to $47.64. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.